Former Bahamas Health Minister warns of risks from illicit GLP-1 weight-loss drug market

Dr. Duane Sands has publicly condemned the purchase of GLP-1 agonists from unlicensed sources, citing risks of counterfeit or contaminated products. The statement highlights growing concerns over the unregulated distribution of high-demand weight-loss medications and the potential for severe patient health outcomes.